Arizona Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.02 Cr
as on 17-07-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 17-07-2024
- Revenue %
(FY 2022)
- Net Worth 47.04%
(FY 2022)
- Total Assets 160.07%
(FY 2022)
About Arizona Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.02 Cr.
The company currently has active open charges totaling ₹9.00 M.
Sanjeev Mukherjee, Sadanand Mandhyan, and Kavita Mandhyan serve as directors at the Company.
- CIN/LLPIN
U01409GJ2020PTC112639
- Company No.
112639
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Taluka Ankleshwar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arizona Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Mukherjee  | Director | 11-Feb-2020 | Current |
| Sadanand Mandhyan | Director | 11-Feb-2020 | Current |
| Kavita Mandhyan | Director | 31-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Arizona Biotech.
Arizona Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 47.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Arizona Biotech?
In 2022, Arizona Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamadhenu Nutrients Private LimitedActive 26 years 9 monthsSadanand Mandhyan and Kavita Mandhyan are mutual person
- Brindavan Phosphates Private LimitedActive 33 years 1 month
Sadanand Mandhyan and Kavita Mandhyan are mutual person
- Cauvery Healthworth Private LimitedActive 4 years 11 months
Sadanand Mandhyan and Kavita Mandhyan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jan 2022 | ₹9.00 M | Open |
How Many Employees Work at Arizona Biotech?
Unlock and access historical data on people associated with Arizona Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arizona Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arizona Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
